Stevanato Group S.p.A. (NYSE:STVN) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lowered its stake in Stevanato Group S.p.A. (NYSE:STVN) by 3.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,706 shares of the company’s stock after selling 622 shares during the period. Bank of New York Mellon Corp’s holdings in Stevanato Group were worth $364,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. The Manufacturers Life Insurance Company lifted its position in shares of Stevanato Group by 16.9% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 294,235 shares of the company’s stock worth $5,885,000 after purchasing an additional 42,629 shares during the last quarter. Glenmede Trust Co. NA lifted its holdings in Stevanato Group by 12.7% during the 3rd quarter. Glenmede Trust Co. NA now owns 35,941 shares of the company’s stock worth $719,000 after buying an additional 4,050 shares during the last quarter. Captrust Financial Advisors boosted its position in shares of Stevanato Group by 12.7% during the 3rd quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock worth $262,000 after acquiring an additional 1,480 shares in the last quarter. Fred Alger Management LLC increased its holdings in shares of Stevanato Group by 24.2% in the 3rd quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock valued at $21,411,000 after acquiring an additional 208,830 shares during the last quarter. Finally, Bamco Inc. NY raised its position in shares of Stevanato Group by 1.3% during the 3rd quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock worth $33,704,000 after acquiring an additional 21,469 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on STVN shares. Wolfe Research assumed coverage on Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. Bank of America upped their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. UBS Group decreased their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday, March 7th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of €25.70 ($27.93).

Stevanato Group Trading Down 0.3 %

Shares of Stevanato Group stock opened at €20.25 ($22.01) on Friday. The company’s fifty day moving average is €20.90 and its two-hundred day moving average is €20.59. Stevanato Group S.p.A. has a 1 year low of €16.56 ($18.00) and a 1 year high of €32.98 ($35.85). The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The company has a market capitalization of $6.13 billion, a P/E ratio of 43.09, a PEG ratio of 7.18 and a beta of 0.60.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting the consensus estimate of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €352.68 million for the quarter, compared to analysts’ expectations of €346.26 million. Analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.